D010051DisordersC04.588.322.455C13.351.500.056.630.705C13.351.937.418.685C19.344.410C19.391.630.70561946210.315794Ovarian NeoplasmsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonExperimental TherapeuticsGynecological Oncology & Reproductive MedicineSystems BiologyMD AndersonROBERT CBAST JRROBERT C BAST JR8483BAST JR, ROBERT CProfessorGORDON BMILLSGORDON B MILLS8620MILLS, GORDON BProfessorKAREN HLUKAREN H LU8836LU, KAREN HProfessorROBERTCOLEMANROBERT COLEMAN9184COLEMAN, ROBERTProfessorANIL KSOODANIL K SOOD9048SOOD, ANIL KProfessor74Professor33.46140.00258579619research area of0.9896170.008827262471subject area for38169324Bildik G, Gray JP, Mao W, Yang H, Ozyurt R, Orellana VR, De Wever O, Carey MS, Bast RC, Lu ZAutophagyDIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas. Autophagy. 2024 Mar; 20(3):675-691.Autophagy2024-01-03T00:00:002024DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas.38195887Young Han C, Bedia JS, Yang WL, Hawley SJ, Bergan L, Hopper M, Celestino J, Guo J, Gornet TG, Soosaipillai A, Yang H, Doskocil SD, Lokshin AE, Handy BC, Diamandis EP, Moore RG, Lu KH, Lu Z, Anderson KS, Drescher CW, Skates SJ, Bast RCBritish journal of cancerAutoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer. Br J Cancer. 2024 Mar; 130(5):861-868.Br J Cancer2024-01-09T00:00:002024Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.38184155Lu Y, Lindheim SR, Sun YFertility and sterilityOpportunistic salpingectomy at cesarean delivery: Is it a worthy choice? Fertil Steril. 2024 Mar; 121(3):446-447.Fertil Steril2024-01-04T00:00:002024Opportunistic salpingectomy at cesarean delivery: Is it a worthy choice?38307807Ledermann JA, Matias-Guiu X, Amant F, Concin N, Davidson B, Fotopoulou C, Gonz?lez-Martin A, Gourley C, Leary A, Lorusso D, Banerjee S, Chiva L, Cibula D, Colombo N, Croce S, Eriksson AG, Falandry C, Fischerova D, Harter P, Joly F, Lazaro C, Lok C, Mahner S, Marm? F, Marth C, McCluggage WG, McNeish IA, Morice P, Nicum S, Oaknin A, P?rez-Fidalgo JA, Pignata S, Ramirez PT, Ray-Coquard I, Romero I, Scambia G, Sehouli J, Shapira-Frommer R, Sundar S, Tan DSP, Taskiran C, van Driel WJ, Vergote I, Planchamp F, Sessa C, Fagotti AAnnals of oncology : official journal of the European Society for Medical OncologyESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease. Ann Oncol. 2024 Mar; 35(3):248-266.Ann Oncol2024-02-01T00:00:002024ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.38309721Amaria R, Knisely A, Vining D, Kopetz S, Overman MJ, Javle M, Antonoff MB, Tzeng CD, Wolff RA, Pant S, Lito K, Rangel K, Fellman B, Yuan Y, Lu KH, Sakellariou-Thompson D, Haymaker CL, Forget MA, Hwu P, Bernatchez C, Jazaeri AAJournal for immunotherapy of cancerEfficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma. J Immunother Cancer. 2024 Feb 02; 12(2).J Immunother Cancer2024-02-02T00:00:002024Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor